Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Agents for hepatitis C under study at Vertex

Dec. 7, 2001

New phase III trial initiated for alicaforsen in Crohn's disease

Dec. 4, 2001

New substituted adenine interferon inducers under study by Japan Energy and Sumitomo

Nov. 30, 2001

Basiliximab: use in GI inflammatory disorders

Nov. 29, 2001

Hepatoprotectant ME-3738 appears to act via an IL-6-dependent mechanism

Nov. 29, 2001

Chiron grants nonexclusive HCV license to BMS

Nov. 29, 2001

Extensive coverage of ICN's second-generation ribavirin analogues at AASLD

Nov. 29, 2001

Tanabe Seiyaku improves pancreas selectivity of CCK-A receptor antagonists

Nov. 29, 2001

New gastric antisecretory agents designed by Byk Gulden

Nov. 26, 2001

AASLD news: Gilead's adefovir dipivoxil improves liver function and reduces viral load in HBV

Nov. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...